Loading...
XNAS
OPRX
Market cap115mUSD
Jul 09, Last price  
6.28USD
1D
2.11%
1Q
2.45%
Jan 2017
675.31%
IPO
1,395.24%
Name

OPTIMIZERx Corp

Chart & Performance

D1W1MN
XNAS:OPRX chart
P/E
22.96
P/S
1.08
EPS
0.27
Div Yield, %
Shrs. gr., 5y
5.08%
Rev. gr., 5y
20.37%
Revenues
109m
+18.78%
100,31883,68626,72371,0651,111,5202,048,6994,957,0166,502,9627,220,6787,751,46212,127,42221,206,36324,598,27443,313,32361,292,59862,450,15671,522,00092,127,000109,429,000
Net income
5m
P
-361,466-4,248,853-4,555,689-2,009,024-2,120,762-363,976215,847-1,025,393-595,140-1,539,203-2,104,029226,344-3,142,576-2,207,127378,079-11,438,440-17,566,000-20,110,0005,132,000
CFO
19m
+282.80%
-303,633-919,402-1,769,562-1,311,413-521,509-624,0331,132,628-56,350515,110-465,965-1,479,831792,555-1,660,796-6,310,386726,03910,654,078-7,240,0004,889,00018,715,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

OptimizeRx Corp. is digital health company, engaged in the provision of digital health messaging via electronic health records, which serve as a direct channel for pharmaceutical companies to communicate with healthcare providers. It offers electronic health record (EHR) workflow solutions which include financial messaging, patient education, and brand messaging and brand support. The company was founded by David A. Harrell in 2006 and is headquartered in Waltham, MA.
IPO date
May 18, 2005
Employees
109
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT